Selank and Semax are synthetic heptapeptides developed in Russia, but they target distinct neurological pathways. While Selank acts primarily as a GABA-mod
Read more Selank vs. Semax: Comparing Mechanisms and Research Evidence
Delta sleep-inducing peptide (DSIP) remains one of neurobiology’s most persistent puzzles. Isolated nearly five decades ago, its biological receptors, gene
Read more Delta Sleep-Inducing Peptide (DSIP): Unresolved Mechanisms and Research Challenges
Semax and Selank are synthetic heptapeptides developed from distinct endogenous parent molecules. While Semax targets neurotrophin expression and neuroprot
Read more Semax vs. Selank: Comparative Mechanisms, Neurochemistry, and Research Evidence
Adamax is an experimental peptide derived from Semax by adding an N-terminal acetyl group and a C-terminal adamantane moiety. This comparative analysis exa
Read more Adamax vs. Semax: Chemical Modifications, Preclinical Research, and Evidence Gaps
Semax is a synthetic ACTH(4-7) analog investigated for acute ischemic stroke and neurological rehabilitation. Research demonstrates that it upregulates BDN
Read more Semax in Ischemic Stroke Research: Mechanisms and Clinical Trials
A scientific review of human clinical trials evaluating oxytocin. Explore the evidence across obstetrics, neuropsychiatry, social cognition, and delivery m
Read more Oxytocin Human Studies: What Does the Clinical Evidence Show?